NCT06741150View on ClinicalTrials.gov

NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients.

NARecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 24, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Intraepithelial NeoplasiaCervical Cancer
Interventions
BIOLOGICAL

NWRD09 administered by intramuscular injection

Intramuscular injection administration was carried out according to the protocol design.

Trial Locations (1)

214062

RECRUITING

Affiliated Hospital of Jiangnan University, Wuxi

All Listed Sponsors
lead

Newish Technology (Beijing) Co., Ltd.

INDUSTRY